Baxter International saw the highest growth of 1.42% in patent filings in May and 1.13% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.09% and grants by 1.13%. GlobalData’s DataBook provides a comprehensive analysis of Baxter International‘s patent filings and grants. Buy the databook here.
Baxter International has been focused on protecting inventions in United States(US) with 97 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 32% filings and 38% grants. The United States(US), Australia(AU), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Baxter International is filings its patents. Among the top granted patent authorities, Baxter International has 38% of its grants in United States(US), 23% in European Patent Office(EPO) and 15% in China(CN).
Terumo and Fresenius Medical Care could be the strongest competitors for Baxter International
In terms of grant share, Baxter International stands first among its competitors followed by Terumo and Fresenius Medical Care.
Patents related to healthtech and remote patient monitoring lead Baxter International's portfolio
Baxter International has the highest number of patents in healthtech followed by, remote patient monitoring and smart hospitals. For healthtech, nearly 20% of patents were filed and 22% of patents were granted in Q2 2024.
Nephrology and urology devices related patents lead Baxter International portfolio followed by healthcare it, and other remote patient monitoring
Baxter International has highest number of patents in nephrology and urology devices followed by healthcare it, other remote patient monitoring, hospital supplies, and drug delivery devices. For nephrology and urology devices, nearly 27% of patents were filed and 16% of patents were granted in Q2 2024.
For comprehensive analysis of Baxter International's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.